Table 2. Univariate/Multivariate cox analyses of recurrence-free survival.
Factor | Cox analysis | Multivariate Cox analysis | ||||
b | P | HR(95% CI) | b | P | HR(95% CI) | |
Gende r(male/female) | -0.009 | 0.957 | 0.71-1.384 | |||
Age (>65 years/<=65 years) | -0.030 | 0.854 | 0.709-1.329 | |||
Grade (G3-4/G1-2) | 0.101 | 0.538 | 0.803-1.524 | |||
T stage (T3-4/T1-2) | 0.887 | 0.000 | 1.735-3.400 | 0.708 | 0.484 | 0.28-14.746 |
Lymph node stage (N2-3/N0-1) | 0.343 | 0.631 | 0.348-5.715 | |||
Metastasis (M1/M0) | 0.909 | 0.206 | 0.607-10.150 | |||
Pathological stage (III-IV/I-II) | 0.865 | 0.000 | 1.7-3.3200 | 0.121 | 0.904 | 0.157-8.107 |
HGSVA score (high/low) | 0.554 | 0.001 | 1.269-2.387 | 0.474 | 0.004 | 1.168-2.211 |
HR, Hazard Ratio; CI, confidence interval; HGSVA, hub gene set variation analysis.